United States v. Deion Jones

CourtCourt of Appeals for the Fourth Circuit
DecidedMay 29, 2019
Docket18-4765
StatusUnpublished

This text of United States v. Deion Jones (United States v. Deion Jones) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fourth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Deion Jones, (4th Cir. 2019).

Opinion

UNPUBLISHED

UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT

No. 18-4765

UNITED STATES OF AMERICA,

Plaintiff - Appellee,

v.

DEION J. JONES,

Defendant - Appellant.

Appeal from the United States District Court for the Northern District of West Virginia, at Wheeling. Frederick P. Stamp, Jr., Senior District Judge. (5:17-cr-00027-FPS-JPM-3)

Submitted: May 20, 2019 Decided: May 29, 2019

Before GREGORY, Chief Judge, NIEMEYER, Circuit Judge, and SHEDD, Senior Circuit Judge.

Affirmed by unpublished per curiam opinion.

Diana Stavroulakis, Weirton, West Virginia, for Appellant. William J. Powell, United States Attorney, Robert H. McWilliams, Jr., Assistant United States Attorney, OFFICE OF THE UNITED STATES ATTORNEY, Wheeling, West Virginia, for Appellee.

Unpublished opinions are not binding precedent in this circuit. PER CURIAM:

Deion J. Jones appeals the 37-month sentence imposed following his guilty plea to

distributing an unspecified quantity of oxycodone, in violation of 21 U.S.C. § 841(a)(1),

(b)(1)(C) (2012). The lone issue presented on appeal is whether the district court clearly

erred in determining the drug quantity attributable to Jones for sentencing purposes. As

discussed below, we find no clear error in the district court’s ruling and thus affirm.

In reviewing any federal sentence, we are charged with first ensuring that the

district court did not commit any “significant procedural error,” such as failing to

properly calculate the applicable Sentencing Guidelines range, consider the 18 U.S.C.

§ 3553(a) (2012) factors, or adequately explain the sentence. Gall v. United States, 552

U.S. 38, 51 (2007). If a party asserts on appeal a claim of procedural sentencing error

that it preserved before the district court, we review for abuse of discretion and will

reverse unless we conclude that the error was harmless. United States v. Lynn, 592 F.3d

572, 576 (4th Cir. 2010). In evaluating a challenge to the district court’s computation of

a defendant’s Guidelines range, this court reviews for clear error the underlying factual

determinations made by the district court and reviews de novo the relevant legal

conclusions. See United States v. Alvarado Perez, 609 F.3d 609, 612 (4th Cir. 2010).

Of course, “the district court’s calculation of the quantity of drugs attributable to a

defendant for sentencing purposes” is a classic factual determination that we review only

for clear error. United States v. Crawford, 734 F.3d 339, 342 (4th Cir. 2013) (internal

quotation marks omitted). “A finding is clearly erroneous when although there is

evidence to support it, the reviewing court on the entire evidence is left with the definite

2 and firm conviction that a mistake has been committed.” United States v. Wooden, 887

F.3d 591, 602 (4th Cir. 2018) (internal quotation marks omitted).

The Government must prove the drug quantity attributable to the defendant by a

preponderance of the evidence. United States v. McGee, 736 F.3d 263, 271 (4th Cir.

2013). “Under the Guidelines, the drug quantities that may be attributed to the defendant

include the quantities associated with the defendant’s offense of conviction and any

relevant conduct.” United States v. Flores-Alvarado, 779 F.3d 250, 255 (4th Cir. 2015).

Where, as here, “the drug quantity is not proven by actual seizures or comparable direct

evidence, the government must present evidence from which the sentencing court may

approximate the quantity.” United States v. Bell, 667 F.3d 431, 441 (4th Cir. 2011)

(internal quotation marks omitted). When approximating such an attributable drug

quantity, “the Sentencing Guidelines allow courts to consider relevant information

without regard to its admissibility under the rules of evidence applicable at trial, provided

that the information has sufficient indicia of reliability to support its probable accuracy.”

Crawford, 734 F.3d at 342 (internal quotation marks omitted).

In the presentence report, the probation officer utilized conservative estimates of

Jones’ relevant conduct to calculate the attributable drug quantity. Specifically, the

probation officer relied on the statement of one of Jones’ codefendants—to wit, that

Jones participated in trafficking oxycodone between Philadelphia and West Virginia three

times in 2014—instead of crediting other evidence that supported a finding that Jones

trafficked oxycodone many more times. The probation officer further relied on a more

conservative estimate as to the number of tablets trafficked each time—300—than

3 otherwise reported. Based on these facts, the probation officer recommended finding that

Jones was accountable for 900 30-mg oxycodone tablets. This totaled 27,000 milligrams,

or 27 grams, of oxycodone. As 1 gram of oxycodone is the equivalent of 6700 grams of

marijuana, the 27 grams of oxycodone converted to 180,900 grams, or 180.9 kilograms,

of marijuana. See U.S. Sentencing Guidelines Manual § 2D1.1 app. n.8(D) (Drug

Equivalency Tables) (2016). This resulted in a base offense level of 24. See USSG

§ 2D1.1(c)(8) (offense level 24 applies to conduct involving more than 100 but less than

400 kilograms of marijuana).

Jones objected to these findings but, based on the evidence presented at

sentencing, the district court adopted the recommended finding that Jones transported

oxycodone three times. The court further found that, while the witness testimony

regarding the transported quantities lacked exactitude, it substantiated the 300-pills-per-

trip finding recommended in the PSR. In light of this credited testimony, we find no

clear error in the district court’s adoption of the probation officer’s recommendation as to

the drug quantity attributable to Jones. See United States v. McDowell, 745 F.3d 115,

120 (4th Cir. 2014) (noting the “considerable deference” this court affords “to a district

court’s determinations regarding the reliability of information in a PSR,” and reaffirming

that this court “will not disturb a court’s determination regarding the reliability of a PSR

unless . . . left with the definite and firm conviction that a mistake has been committed”

(internal quotation marks omitted)).

Because the assigned basis for reversal lacks merit, we affirm Jones’ criminal

judgment. We dispense with oral argument because the facts and legal contentions are

4 adequately presented in the materials before this court and argument would not aid the

decisional process.

AFFIRMED

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Gall v. United States
552 U.S. 38 (Supreme Court, 2007)
United States v. Alvarado Perez
609 F.3d 609 (Fourth Circuit, 2010)
United States v. Bell
667 F.3d 431 (Fourth Circuit, 2011)
United States v. Lynn
592 F.3d 572 (Fourth Circuit, 2010)
United States v. Kendrick Crawford
734 F.3d 339 (Fourth Circuit, 2013)
United States v. Randall McGee
736 F.3d 263 (Fourth Circuit, 2013)
United States v. Ernest McDowell, Jr.
745 F.3d 115 (Fourth Circuit, 2014)
United States v. Marco Flores-Alvarado
779 F.3d 250 (Fourth Circuit, 2015)
United States v. Walter Wooden
887 F.3d 591 (Fourth Circuit, 2018)

Cite This Page — Counsel Stack

Bluebook (online)
United States v. Deion Jones, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-deion-jones-ca4-2019.